Wednesday , 4 December 2024
Home Novo Nordisk CEO

Novo Nordisk CEO

Lars Fruergaard Jørgensen
Healthcare

Novo Nordisk CEO Defends Ozempic Pricing in Senate Hearing

In a recent Senate testimony, Lars Jørgensen, the CEO of Novo Nordisk, defended the pricing of Ozempic, the company’s widely used medication for...